Increasingly Transformed MCF-10A Cells Have a Progressively Tumor-like Phenotype in Three-dimensional Basement Membrane Culture
Overview
Affiliations
Background: MCF-10A cells are near diploid and normal human mammary epithelial cells. In three-dimensional reconstituted basement membrane culture, they undergo a well-defined program of proliferation, differentiation, and growth arrest, forming acinar structures that recapitulate many aspects of mammary architecture in vivo. The pre-malignant MCF-10AT cells and malignant MCF-10CA1a lines were sequentially derived from the MCF-10A parental cell line first by expression of a constitutively active T24 H-Ras generating the MCF-10AT cell line. This was followed by repeated selection for increasingly aggressive tumor formation from cells recovered from xenograft tumors in immuno-compromised mice, generating the MCF-10CA1a cell line. When inoculated subcutaneously into the flanks of immuno-compromised mice, MCF-10AT cells occasionally form tumors, whereas MCF-10CA1a cells invariably form tumors with a shorter latency than MCF-10AT derived tumors.
Results: MCF-10AT cells grown in three-dimensional basement membrane culture form complex multi-acinar structures that produce a basement membrane but undergo delayed cell cycle arrest and have incomplete luminal development. MCF-10CA1a cells grown in three-dimensional basement membrane culture form large, hyper-proliferative masses, that retain few characteristics of MCF10A acini and more closely resemble tumors.
Conclusion: Here we report on the growth and differentiation properties of these three matched cell lines in three-dimensional basement membrane culture. Features of tissue morphogenesis were assessed, including proliferation, basement membrane formation, polarization of alpha-6 beta-4 integrin to the basement membrane, formation of cell:cell junctions, and apoptosis for luminal clearance. The matched series of normal MCF-10A, pre-malignant MCF-10AT, and malignant MCF-10CA1a cells offers a unique opportunity to study the mechanisms of malignant progression both in a three-dimensional microenvironment and in the same cell background.
Lyu S, Meshesha S, Hong C Int J Mol Sci. 2025; 26(1.
PMID: 39796221 PMC: 11719730. DOI: 10.3390/ijms26010366.
Jackson P, Kisty E, Pradhan V, Swank C, Bohrer L, Nolan T ACS Omega. 2024; 9(41):42557-42570.
PMID: 39431108 PMC: 11483914. DOI: 10.1021/acsomega.4c06879.
Ciciro Y, Ragusa D, Nevado P, Lattanzio R, Sala G, DesRochers T FEBS Lett. 2023; 598(2):252-265.
PMID: 38112379 PMC: 11774229. DOI: 10.1002/1873-3468.14786.
Vydra N, Toma-Jonik A, Janus P, Mrowiec K, Stokowy T, Glowala-Kosinska M Cancers (Basel). 2023; 15(20).
PMID: 37894333 PMC: 10605143. DOI: 10.3390/cancers15204965.
Laroche F, Li S, Shen N, Hwang S, Nguyen G, Yu W Cells. 2023; 12(7).
PMID: 37048053 PMC: 10093541. DOI: 10.3390/cells12070980.